We therefore investigated the potential clinical relevance of the p53 gene codon 72 SNP in a cohort of 138 samples from patients with B-CLL with respect to survival and drug sensitivity. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.